FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Baxter's Preflucel gets EU OK

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools

Baxter International has received the approval of a European repeat mutual recognition procedure by the Austrian Agency for Health and Food Safety for the Preflucel seasonal influenza vaccine. The 13 participating EU countries, including Germany, Spain, UK and Nordic countries, will formally implement the license on a national level to make Preflucel available for the 2011-12 influenza season. Baxter release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Baxter International   Preflucel   European Union